13 results
Early Events in Acute GVHD #Pathophys #Honc #GVHD #GraftVersusHostDisease #NEJM
in Acute GVHD #Pathophys ... #Honc #GVHD #GraftVersusHostDisease ... #NEJM
Possible Mechanisms Underlying Immune-Related Adverse Events #Pathophys #Honc #ImmuneRelatedAdverseEvents #Immunotherapy #NEJM
Adverse Events #Pathophys ... #Honc #ImmuneRelatedAdverseEvents ... Immunotherapy #NEJM
Biologic Events Leading to Chronic GVHD #Pathophys #Honc #Pharm #GVHD #GraftVersusHostDisease #Therapeutic #Pathways #NEJM
Chronic GVHD #Pathophys ... #Honc #Pharm #GVHD ... Therapeutic #Pathways #NEJM
Role of G6PD in Protection against Oxidative Damage #Pathophys #Peds #Genetics #Honc #Favism #g6pd #NEJM
Oxidative Damage #Pathophys ... Peds #Genetics #Honc ... #Favism #g6pd #NEJM
Paths to Defective Homologous Recombination DNA Repair in Breast Cancer. Each individual mutation or epigenetic aberration
DNA Repair in Breast ... common feature of breast ... cancer #Pathophys ... #Honc #BreastCancer ... #DNARepair #NEJM
The Pathway of Heme Synthesis, Showing Pathway Intermediates and End-Product Regulation by Heme #Pathophys #Honc #Heme
Regulation by Heme #Pathophys ... #Honc #Heme #Synthesis ... #Porphyria #NEJM
#Pathophys #Peds #Genetics #Honc #Favism #g6pd #NEJM
#Pathophys #Peds ... #Genetics #Honc ... #Favism #g6pd #NEJM
The Mechanism of Small Interfering RNA (siRNA) Therapy. Synthetic double-stranded RNA containing an ALAS1-specific sequence is
#Pathophys #Honc ... siRNA #Therapy #NEJM
Radiation-Induced Angiosarcoma after Breast-Cancer Treatment - Physical examination revealed an area of skin 10 cm in
Angiosarcoma after Breast-Cancer ... the dermis and breast ... Clinical #Derm #Honc ... #Angiosarcoma #Breast ... Radiation #Microscopy #NEJM
Uremic Frost in End-Stage Renal Disease- A 39-year-old man with end-stage renal disease presented to the
showed a blood urea ... crystallization of urea ... #NEJM #clinical ... #photo #renal #urology ... #urea